Clinical Laserthermia Systems AB (publ) Strategic Asset Allocation Index
Clinical Laserthermia Systems AB (publ) strategic asset allocation index. Clinical Laserthermia Systems AB (publ) (CLS-B) has a Strategic Asset Allocation Index of 22.9% as of December 2022. Strategic assets (PP&E of Skr1.80 Million plus long-term investments of Skr-) total Skr1.80 Million, measured against net assets of Skr7.87 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Clinical Laserthermia Systems AB (publ)'s balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Clinical Laserthermia Systems AB (publ) (2017–2022)
Strategic asset allocation index of Clinical Laserthermia Systems AB (publ) from 2017 to 2022. This chart shows how Clinical Laserthermia Systems AB (publ)'s Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of December 2022, the index stands at 22.9%, representing strategic assets of Skr1.80 Million against net assets of Skr7.87 Million SEK. Check Clinical Laserthermia Systems AB (publ) tangible book value ratio to evaluate the tangible quality of the company's equity base.
Clinical Laserthermia Systems AB (publ) Strategic Asset Allocation Index by Year (2017–2022)
Clinical Laserthermia Systems AB (publ) strategic asset allocation index by year from 2017 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Clinical Laserthermia Systems AB (publ) from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Clinical Laserthermia Systems AB (publ).
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 22.9% | Skr1.80 Million | Skr1.80 Million | Skr- | Skr7.87 Million | ▲ +16.0 pp |
| 2021 | 7.0% | Skr1.48 Million | Skr1.48 Million | Skr- | Skr21.18 Million | ▼ -7.8 pp |
| 2020 | 14.7% | Skr2.05 Million | Skr2.05 Million | Skr- | Skr13.93 Million | ▼ -19.7 pp |
| 2019 | 34.4% | Skr2.41 Million | Skr2.41 Million | Skr- | Skr7.00 Million | ▲ +33.2 pp |
| 2018 | 1.2% | Skr620.00K | Skr620.00K | Skr- | Skr49.81 Million | ▼ -1.2 pp |
| 2017 | 2.5% | Skr821.00K | Skr821.00K | Skr- | Skr33.00 Million | — |